Optimal Duration of Antiplatelet Therapy After Bioresorbable Vascular Scaffold Implantation to Reduce Late Coronary Arterial Thrombotic Events (BVS LATE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT02939872

Recruitment Status : Active, not recruiting

First Posted : October 20, 2016

Last Update Posted : June 23, 2021

Sponsor:

Collaborator:

CardioVascular Research Foundation, Korea

Information provided by (Responsible Party):

Seung-Jung Park, Asan Medical Center

Study Details
Tabular View
No Results Posted
Disclaimer
How to Read a Study Record

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Active, not recruiting
Actual Primary Completion Date :	May 9, 2021
Estimated Study Completion Date :	June 30, 2024

To Top